CytoVac AB

Biotech company with Phase II Clinical Trials - ALECSAT - CAR-T cell therapy - Orphan Drug

General Information
Company Name
CytoVac AB
Founded Year
2008
Location (Offices)
+1
Founders / Decision Makers
Number of Employees
10
Industries
Biotechnology, Health Care
Funding Stage
Series Unknown
Social Media

CytoVac AB - Company Profile

Cytovac has the key to immunotherapy Cytovac is a growing Danish biotech company, focusing on development of a cancer treatment that uses the body’s own immune system. Promising results gained by the dedicated research team over a number of years, have brought about the development of the ALECSAT therapy. ALECSAT is a therapy based on injection of activated cells from the immune system. These cells will attack the cancer cells and activate the immune system in the patients. As Cytovac solely apply the patient’s own cells, this therapy is gentle and without the serious side effects normally associated with cancer treatment. Cytovac has been granted Orphan Drug Designation by the European (EMA) as well as the American (FDA) medicines agencies in support to the company’s brain-cancer project. Cytovac has generated convincing data with the ALECSAT treatments in three clinical phase I trials targeted at treatment of prostate cancer, pancreatic cancer and brain cancer. So far more than 100 cancer patients have been treated, with more than 250 doses of ALECSAT. So Cytovac has a platform that may prove to be an efficacious treatment for several types of cancer. Cytovac has since 2015 concentrated all clinical efforts on brain cancer, and here the company is currently conducting clinical phase II trials. Cytovac is dedicated to treatment of cancer by using our key to immunotherapy.

Funding Rounds & Investors of CytoVac AB (0)

View All

There is no investment information

Latest News of CytoVac AB

View All

No recent news or press coverage available for CytoVac AB.

Similar Companies to CytoVac AB

View All
Treovir Inc. - Similar company to CytoVac AB
Treovir Inc. For the kids
ImmunoCellular Therapeutics Ltd - Similar company to CytoVac AB
ImmunoCellular Therapeutics Ltd Pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development.
Lineage Cell Therapeutics - Similar company to CytoVac AB
Lineage Cell Therapeutics A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.